Having microscopic polyangiitis (MPA) or granulomatosis with polyangiitis (GPA) — the two most common types of ANCA-associated vasculitis (AAV)…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
ANCA-associated vasculitis (AAV) patients receiving a cumulative dose of at least 935 mg of glucocorticoids over six months are…
Recruitment is continuing in three countries for a Phase 1b/2a clinical trial testing Alpine Immune Sciences’ povetacicept in adults…
The Renal Risk Score may be a better histopathologic classification model than Berden for predicting long-term loss of kidney function…
The Kidney Disease: Improving Global Outcomes (KDIGO) work group has released an updated practice guideline based on developments…
Tavneos (avacopan) improved kidney function and reduced the need for the glucocorticoid prednisone in four older patients who had…
Certain clotting markers are found at higher levels in the blood of people with ANCA-associated vasculitis (AAV) when their…
A higher eosinophil count at diagnosis is linked to more severe disease activity in people with microscopic polyangiitis (MPA) or…
Evotec has formed a partnership with Charité – Universitätsmedizin Berlin in Germany to build a database of all sorts…
Factor XII (FXII), a protein involved in blood clotting, is found at significantly higher levels in the blood of people…